Background. The pathogenic mechanisms and the antigens involved in the
establishment and progress of IgA nephropathy are unknown. As antibod
ies against C1q have been reported to correlate with SLE nephritis, we
analysed the occurrence of these antibodies in IgA nephropathy in ord
er to investigate the possibility of pathogenetic similarities in thes
e renal disorders. Methods. The occurrence of IgA- and IgG anti-C1q an
tibodies (anti-C1q) were determined by ELISA in patients with IgA neph
ropathy (n = 36) and SLE nephritis (n = 37), diseases both known to be
associated with circulating immune complexes. Levels of these antibod
ies were also determined in two other glomerular diseases, i.e. idiopa
thic membranous glomerulonephritis (n = 7) and minimal change disease
(n = 2), in which circulating immune complexes are usually not present
, and in 40 healthy controls. Results. IgA anti-C1q was observed in in
creased titres in 11/36 of the patients with IgA nephropathy, in 2/37
of the patients with SLE nephritis (both with proliferative disease) a
nd in 1/9 of the patients with membranous and minimal change disease (
P<0.001). Increased titres of IgG anti-C1q were observed in 1/36 of th
e patients with IgA nephropathy, in 17/37 of the patients with SLE nep
hritis and in 0/9 of the patients with membranous and minimal change d
isease (P<0.001). There were no correlations between the levels of ant
i-C1q antibodies and clinical parameters such as degree of proteinuria
, haematuria, or renal function. Nor was there any correlation to the
concentration of C3a and the terminal complement complex (TCC) in pati
ents with IgA nephropathy. Conclusions. The occurrence of anti-C1q ant
ibodies in both IgA nephropathy and SLE nephritis, albeit of different
predominating isotypes, indicates the possibility of a similar pathog
enic mechanism involved in these renal disorders. The occurrence of Ig
A anti-C1q antibodies in patients with IgA nephropathy has to our know
ledge not previously been reported.